These same studies showed a decrease in the activation of latent TGFβ1, both in vitro and in vivo, and indicated that TSP1 deficiency and a decline in latent TGFβ1 activation could be protective against inflammation and obesity. This evidence concerns the gene TGFB1 and obesity disorder.